Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hGH vs Placebo in Intensively Treated Haemato-Oncology Patients
NCT00300664Phase 3Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jul 2002
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
01
Overview
Phase 3, randomised, double-blind trial in cancer cachexia comparing hGH with Placebo (2 arms). Primary endpoints: Loss of muscle mass at 6 weeks and Weight loss at 6 weeks. Started Jul 2002; status: completed.
02
Drugs
somatropin
03
Conditions
cancer cachexia
Beyond the preview
Go deeper on NCT00300664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300664.